Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationEBIATLeasesLoans and Notes ReceivablesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares Outstanding
Ratios

Northwest Biotherapeutics (NWBO) Preferred Shares Issued (2017 - 2024)

Northwest Biotherapeutics' Preferred Shares Issued history spans 8 years, with the latest figure at $267000.0 for Q3 2024.

  • Quarterly results put Preferred Shares Issued at $267000.0 for Q3 2024, down 94.81% from a year ago — trailing twelve months through Dec 2024 was $8.2 million (down 38.48% YoY), and the annual figure for FY2024 was $8.2 million, down 38.48%.
  • Preferred Shares Issued for Q3 2024 was $267000.0 at Northwest Biotherapeutics, down from $4.3 million in the prior quarter.
  • In the past five years, Preferred Shares Issued ranged from a high of $7.8 million in Q4 2022 to a low of $267000.0 in Q3 2024.
  • The 3-year median for Preferred Shares Issued is $3.5 million (2023), against an average of $3.7 million.
  • Peak annual rise in Preferred Shares Issued hit 81.78% in 2024, while the deepest fall reached 94.81% in 2024.
  • Year by year, Preferred Shares Issued stood at $7.8 million in 2022, then tumbled by 55.81% to $3.4 million in 2023, then crashed by 92.22% to $267000.0 in 2024.
  • According to Business Quant data, Preferred Shares Issued over the past three periods came in at $267000.0, $4.3 million, and $3.6 million for Q3 2024, Q2 2024, and Q1 2024 respectively.